Abstract
Background: Mycobacterium tuberculosis (MTB) is an important cause of bacteremia and sepsis in HIV patients residing in sub-Saharan Africa. Many patients with MTB sepsis go undiagnosed and die within 18 days of presentation, making culture inadequate for detecting MTB in the blood. Objective: To determine the feasibility of ambient temperature transport of blood in PrimeStore MTM® to a distant lab for real-time PCR detection of MTB bacteremia and to monitor clearance of MTB from the blood after therapy. Methods & Materials: BALB/c female mice were injected intravenously with 0.2 mls of ethanol killed MTB (approximately 105 CFU/mL). Two anti-MTB opsonophagocytic bactericidal MABs were used to simulate treatment of MTB sepsis. Mouse monoclonal antibodies (MAB LHN-AB9 or LHN-GG9) or control were given IP using 0.3 mls of sterile PBS 24 hours before MTB challenge. To monitor MTB in the blood, mice were bled at 3 time points: immediately after injection with MTB and again at 4 and 24 hours before MTB challenge. Collected blood was placed into citrate tubes and 0.1ml was transferred into PrimeStore MTM®. Samples were transported at ambient temperature from Gaithersburg, MD to San Antonio, TX. DNA was extracted from blood in PrimeStore MTM® and replicate real-time polymerase chain reactions (PCR) were performed using PrimeMix® MTB Complex on an ABI 7500 Instrument. Results: Blood PCRs on specimens obtained 15 minutes after MTB challenge were positive with an average CT value of 29.8 (range 29.2-30.6). Mice treated with PBS control had MTB detected in the blood by PCR at all time points (at 15 min, 4 and 24 hours post challenge). Mice given anti-TB opsonic MABs cleared the MTB from the blood either by 4 or 24 hours (CT = 40). Conclusion: Blood specimens were efficiently transported to a central lab to detect MTB bacteremia by PCR. In addition, PCR may be useful to monitor patient treatment, similar to viral load testing for HIV. Using PrimeStore MTM® to ship specimens safely and rapidly at ambient temperature to a regional facility for PCR analysis may provide rural hospitals in sub-Saharan Africa the opportunity to diagnose MTB sepsis and monitor treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.